President Bush’s antiregulation bill
Executive Summary
During a campaign stop at the medical device company Stryker in Kalamazoo, Mich. on March 13, the President said he will introduce "reform legislation to correct unreasonable rules we can't change simply through executive action." He says the proposal will be unveiled after expiration of the 90-day regulatory freeze imposed in his Jan. 28 State of the Union address. Bush added that "over-regulation" in the U.S. is a serious threat to the strong competitive position the U.S. medical technology segment now holds in world markets.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth